Role of epigenetic alterations in cholangiocarcinoma.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Hepato-Biliary-Pancreatic Surgery

• Publication date

  2006-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/S00534-005-1055-3PMID 16858537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma

  2005cited by this paper
• Less Is (Usually) More: When Is Amputation Appropriate for Treatment of Extremity Soft Tissue Sarcoma?

  2005cited by this paper
• Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors

  2005cited by this paper
• Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma.

  2005cited by this paper
• Tumor Progression Through Epigenetic Gene Silencing of O6−Methylguanine-DNA Methyltransferase in Human Biliary Tract Cancers

  2005cited by this paper
• Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma.

  2005cited by this paper
• The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma

  2004cited by this paper
• Promoter hypermethylation of DAP‐kinase is associated with poor survival in primary biliary tract carcinoma patients

  2004cited by this paper
• Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.

  2004cited by this paper
• Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis.

  2004cited by this paper
• Possible stem cell origin of human cholangiocarcinoma.

  2004cited by this paper
• The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex

  2004cited by this paper
• Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas

  2004cited by this paper
• Control of microtubule stability by the RASSF1A tumor suppressor

  2003cited by this paper
• Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers

  2003cited by this paper
• Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.

  2003cited by this paper
• Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.

  2003cited by this paper
• Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma

  2003cited by this paper
• Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines

  2002cited by this paper
• Microsatellite instability in thorotrast‐induced human intrahepatic cholangiocarcinoma

  2002cited by this paper
• Liver fluke‐associated cholangiocarcinoma

  2002cited by this paper
• Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma.

  2002cited by this paper
• Genetic and epigenetic alterations of the INK4a–ARF pathway in cholangiocarcinoma

  2002cited by this paper
• Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma.

  2002cited by this paper
• p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma.

  2002cited by this paper
• Microsatellite Instability in Intraductal Papillary Neoplasms of the Biliary Tract

  2002cited by this paper
• The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation

  2002cited by this paper
• A Comparison of DNA Copy Number Changes Detected by Comparative Genomic Hybridization in Malignancies of the Liver, Biliary Tract and Pancreas

  2001cited by this paper
• Accelerated age-related CpG island methylation in ulcerative colitis.

  2001cited by this paper
• Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.

  2001cited by this paper
• p16(INK4a) Promoter hypermethylation of non-tumorous tissue adjacent to gastric cancer is correlated with glandular atrophy and chronic inflammation.

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis

  2001cited by this paper
• DAP kinase-a proapoptotic gene that functions as a tumor suppressor.

  2001cited by this paper
• Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B

  2001cited by this paper
• E‐cadherin gene mutations in human intrahepatic cholangiocarcinoma

  2001cited by this paper
• p16INK4a Promoter hypermethylation of non‐tumorous tissue adjacent to gastric cancer is correlated with glandular atrophy and chronic inflammation

  2001cited by this paper
• Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3

  2000cited by this paper
• Mutations of p53 Tumor Suppressor Gene, Apoptosis, and Proliferation in Intrahepatic Cholangiocellular Carcinoma of the Liver

  2000cited by this paper
• Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial.

  2000cited by this paper
• Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.

  2000cited by this paper
• Allelic loss in human intrahepatic cholangiocarcinoma: Correlation between chromosome 8p22 and tumor progression

  2000cited by this paper
• Frequency of p16INK4A alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liver

  2000cited by this paper
• Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.

  2000cited by this paper
• GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.

  2000cited by this paper
• Promoter methylation and silencing of the retinoic acid receptor-beta in lung cancer

  2000cited by this paper
• DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

  2000cited by this paper
• DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

  1999cited by this paper
• Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.

  1999cited by this paper
• Genomic imprinting and cancer.

  1999cited by this paper
• Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.

  1999cited by this paper
• Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.

  1999cited by this paper
• The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFbeta RII, IGFII R, and BAX genes.

  1998cited by this paper
• Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.

  1998cited by this paper
• CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.

  1998cited by this paper
• Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.

  1998cited by this paper
• Role of the p16 tumor suppressor gene in cancer.

  1998cited by this paper
• Combined hepatocellular carcinoma and cholangiocarcinoma in a mare.

  1997cited by this paper
• Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea.

  1996cited by this paper
• Cholangiocarcinoma in patients with opisthorchiasis

  1996cited by this paper
• Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.

  1995cited by this paper
• Hepatolithiasis associated with cholangiocarcinoma

  1995cited by this paper
• Choledochal cyst disease: P.A. Lipsett, H.A. Pitt, P.M. Colombani, et al. Ann Surg 220:644–652, (November), 1994

  1995cited by this paper
• Prognostic Factors in Cancer

  1995cited by this paper
• Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

  1994cited by this paper
• DNA methylation and genomic imprinting.

  1994cited by this paper
• Choledochal Cyst Disease A Changing Pattern of Presentation

  1994cited by this paper
• Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis.

  1993cited by this paper
• X-chromosome inactivation and cell memory.

  1992cited by this paper
• Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis

  1991cited by this paper
• Cholangiocarcinoma complicating primary sclerosing cholangitis.

  1991cited by this paper
• Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities.

  1991cited by this paper
• Hypomethylation distinguishes genes of some human cancers from their normal counterparts

  1983cited by this paper

• Insights into the electrochemical behaviour of brominated RNA nucleobases at microband screen-printed graphite electrodes

  2025cites this paper
• Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma

  2023cites this paper
• Regulatory function of DNA methylation mediated lncRNAs in gastric cancer

  2022cites this paper
• Involvement of Epigenomic Factors in Bile Duct Cancer.

  2022cites this paper
• FGFR Inhibitors in Cholangiocarcinoma—A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis?

  2022cites this paper
• Liquid biopsy in cholangiocarcinoma: Current status and future perspectives

  2021cites this paper
• Molecular genetic changes in gastric carcinoma

  2020cites this paper
• Primary Liver Cancers—Part 1

  2018cites this paper
• Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers

  2018cites this paper
• Primary Liver Cancers, Part 2

  2018cites this paper
• Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4

  2017cites this paper
• Etiology and Pathogenic Pathways of Cholangiocarcinoma

  2016cites this paper
• Role of SOX17 in the regulation of the biliary phenotype and in cholangiocarcinogenesis

  2016cites this paper
• Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma

  2015cites this paper
• Genetic alteration regulated by microRNAs in biliary tract cancers.

  2015cites this paper
• Epigenetic alterations in gastric cancer (Review)

  2015cites this paper
• Orostachys japonicus DW and EtOH Extracts Induce Apoptosis in Cholangiocarcinoma Cell Line SNU-1079

  2015cites this paper
• Molecular Targets in Biliary Carcinogenesis and Implications for Therapy.

  2015cites this paper
• Molecular mechanism of cholangiocarcinoma carcinogenesis

  2014cites this paper
• OXIDATIVE STRESS AND INFLAMMATION: "THE LESSER OF TWO EVILS" IN CARCINOGENESIS

  2013cites this paper
• Molecular Markers of Cholangiocarcinoma

  2013cites this paper
• Molecular Pathology of Liver Tumors

  2013cites this paper
• DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer

  2013cites this paper
• DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer

  2012cites this paper
• Silencing of miR-370 in Human Cholangiocarcinoma by Allelic Loss and Interleukin-6 Induced Maternal to Paternal Epigenotype Switch

  2012cites this paper
• Genetic profiling of intrahepatic cholangiocarcinoma

  2012cites this paper
• Recent advances in cancer stem cell research for cholangiocarcinoma

  2012cites this paper
• Emerging avenues linking inflammation and cancer.

  2012cites this paper
• Epigenetic aberrations in cholangiocarcinoma: potential biomarkers and promising target for novel therapeutic strategies.

  2012cites this paper
• MicroRNAs and chronic inflammation contribution to gastrointestinal integrity.

  2012cites this paper
• Epigenetic Epidemiology of Infectious Diseases

  2012cites this paper
• Cholangiopathy: Genetics, Mechanism, and Pathology

  2011cites this paper
• Liver tumors: an overview

  2011cites this paper
• DNA methylation biomarkers for colorectal cancer detection: CDO1, DCLK1, ZNF331 and ZSCAN18

  2011cites this paper
• Molecular Pathogenesis of Cholangiocarcinoma

  2011cites this paper
• Liver: Intrahepatic cholangiocarcinoma

  2011cites this paper
• Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma.

  2011cites this paper
• Aberrant DNA methylation profile in cholangiocarcinoma.

  2010cites this paper
• Genetics and Epidemiology of Cholangiocarcinoma

  2010cites this paper
• Molecular mechanisms of cholangiocarcinoma.

  2010cites this paper
• Epidemiologie, Ätiologie und Pathogenese

  2010cites this paper
• Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies.

  2010cites this paper
• Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

  2010cites this paper
• Recent advances in the regulation of cholangiocarcinoma growth.

  2010cites this paper
• Epigenetic Alterations in Cholangiocarcinoma-Sustained IL-6/STAT3 Signaling in Cholangio- carcinoma due to SOCS3 Epigenetic Silencing

  2009cites this paper
• Epigenetic alterations associated with cholangiocarcinoma (review).

  2009influential citation
• Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy

  2008cites this paper
• Inflammation: gearing the journey to cancer.

  2008influential citation
• Genetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs.

  2007cites this paper
• JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

  2007cites this paper
• Title Epigenetic alterations associated with cholangiocarcinoma ( Review ) Author ( s )

  year unknowncites this paper